[1] DASTJERD NT,VALIBEIK A,RAHIMI MONFARED S,et al.Gene therapy:A promising approach for breast cancer treatment[J].Cell Biochem Funct,2022,40(1):28-48.
[2] SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023[J].CA Cancer J Clin, 2023,73(1):17-48.
[3] TRAYES KP,COKENAKES SEH.Breast cancer treatment[J].Am Fam Physician,2021, 104(2):171-178.
[4] ZHANG X,LI Y,SHU C,et al.Suspension state promotes metastasis of breast cancer cells by up-regulating cyclooxygenase-2[J].Theranostics,2018,8(14):3722-3736.
[5] WEN XF,CHEN M,YANG W,et al.Inhibitor of DNA binding 2 inhibits epithelial mesenchymal transition via up-regulation of Notch3 in breast cancer[J].Trans Oncol,2018,11(5):1259-1270.
[6] MURUGESAN M,PREMKUMAR K.Integrative miRNA-mRNA functional analysis identifies miR-182 as a potential prognostic biomarker in breast cancer[J].Mol Omics,2021, 17(4):533-543.
[7] AN M,ZANG X,WANG J,et al.Comprehensive analysis of differentially expressed long noncoding RNAs,miRNAs and mRNAs in breast cancer brain metastasis[J].Epigenomics, 2021,13(14):1113-1128.
[8] TAO L,BEI Y,CHEN P,et al.Crucial role of miR-433 in regulating cardiac fibrosis[J]. Theranostics,2016,6(12):2068-2083.
[9] WANG H,BEI Y,HUANG P,et al.Inhibition of miR-155 protects against LPS-induced cardiac dysfunction and apoptosis in mice[J].Mol Ther Nucleic Acids,2016,5(10): e374.
[10] ZHANG K,GUO L.MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression[J].Gene,2018,641:272-278.
[11] WAN YL,DAI HJ,LIU W,et al.miR-767-3p inhibits growth and migration of lung adenocarcinoma cells by regulating CLDN18[J].Oncol Res,2018,26(4):637-644.
[12] HOUGHTON SC,HANKINSON SE.Cancer progress and priorities:breast cancer[J]. Cancer Epidemiol Biomarkers Prev,2021,30(5):822-844.
[13] GAO YT,ZHOU YC.Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381[J].Eur Rev Med Pharmacol Sci,2019,23(15):6588-6595.
[14] 尹贵彬,金春明,李亚南,等.MicroRNA在乳腺癌中的研究进展[J].牡丹江医学院学报,2021,42(01):175-177,183.
YIN GB,JIN CM,LI YN,et al.Research progress of microRNA in breast cancer[J].Journal of Mudanjiang Medical College,2021,42 (01):175-177,183.
[15] CHENG Y,LI Z,XIE J,et al.MiRNA-224-5p inhibits autophagy in breast cancer cells via targeting Smad4[J].Biochem Bioph Res Co,2018,506(4):793-798.
[16] AHMAD A,ZHANG W,WU M,et al.Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes[J].Genes Genom,2018,40: 243-251.
[17] PATEL Y,SHAH N,BOTBYL R,et al.Abstract 3120:miR-489 function as tumor suppressor miRNA by targeting HER2 in HER2-positive breast cancer[J].Cancer Res,2015,75(15): 3120-3120.
[18] 董孟浩.MRI、WES、RNA-seq在乳腺癌新辅助化疗疗效预测中的价值研究[D].芜湖:皖南医学院,2021.
DONG MH.Study on the value of MRI,WES,RNA seq in predicting the efficacy of neoadjuvant chemotherapy for breast cancer[D].Wuhu:Wannan Medical College,2021.
[19] XU X,ZHOU X,GAO C,et al.Hsa_circ_0018818 knockdown suppresses tumorigenesis in non-small cell lung cancer by sponging miR-767-3p[J].Aging (Albany NY),2020,12(9): 7774-7785.
[20] 裴晓炜. MICRORNA-767-3P在结直肠癌发生发展中的作用及相关机制研究[D].苏州:苏州大学,2020.
PEI XW.Study on the role and mechanism of MicroRNA-767-3p in the occurrence and development of colorectal cancer[D].Suzhou:Suzhou University,2020.
[21] JIANG W,WEN D,GONG L,et al.Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET[J].Biochem Biophys Res Commun,2018,500(2):211-216.
[22] WANG Y,HUANG X,WANG P,et al.The hsa_circ_0007396-miR-767-3p-CHD4 axis is involved in the progression and carcinogenesis of gastric cancer[J].J Gastrointest Oncol, 2022,13(6):2885-2902.
[23] JIA M,LI Z,PAN M,et al.LINC-PINT suppresses the aggressiveness of thyroid cancer by downregulating miR-767-5p to induce TET2 expression[J].Mol Ther Nucleic Acids,2020, 22:319-328.
[24] WANG F,WANG X,LI J,et al.CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling[J].J Biomed Sci,2021, 28(1):4.
[25] KINEMAN RD,DEL RIO-MORENO M,SARMENTO-CABRAL A.40 YEARS of IGF1:Understanding the tissue-specific roles of IGF1/IGF1R in regulating metabolism using the Cre/loxP system[J].J Mol Endocrinol,2018,61(1):T187-T198.
[26] SARFSTEIN R,NAGARAJ K,LEROITH D,et al.Differential effects of insulin and IGF1 receptors on ERK and AKT subcellular distribution in breast cancer cells[J].Cells,2019, 8(12):1499.
[27] LIU L,WANG X,LI X,et al.Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells[J].Oncol Rep, 2018,39(2):818-826.
[28] GIORGI EE,STRAM DO,TAVERNA D,et al.Fine-mapping IGF1 and prostate cancer risk in African Americans:the multiethnic cohort study[J].Cancer Epidemiol Biomarkers Prev, 2014,23(9):1928-1932.
[29] LIU P,ZHANG R,YU W,et al.FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells[J].Biomaterials,2017,149:63-76.
[30]ZHANG Q,LI T,WANG Z,et al.lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway[J].J Cell Mol Med,2020,24(14):8236-8247.
[31]ZOU Y,ZHENG S,XIAO W,et al.circRAD18 sponges miR-208a/3164 to promote triple- negative breast cancer progression through regulating IGF1 and FGF2 expression[J].Carcinogenesis,2019,40(12):1469-1479.
[32] SARKISSYAN S,SARKISSYAN M,WU Y,et al.IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion[J].PLoS One,2014,9(7):e103534.